iatrogenic factors due to the adverse metabolic effects of antiepileptic drugs (AEDs), particularly enzyme-inducing AEDs (EI-AEDs) [i.e. carbamazepine (CBZ), phenytoin (PHT) and phenobarbital (PB)], [9] [10] [11] (c) psychosocial factors including depression and anxiety, [12] [13] [14] [15] [16] [17] and (d) vasculogenic considerations due to vascular risk factors or atherosclerotic changes associated with epilepsy. [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] Vascular comorbidities with epilepsy are not uncommon. However, the possibility of vasculogenic ED with epilepsy is very understudied but may represent a significant consideration due to the fact that chronic epilepsy and its longterm treatment, particularly with EI-AEDs, has been found to be associated with adverse vascular profiles including increased levels of von Willbrand factor (vWF), fibrinogen and oxidized low density lipoprotein (Ox-LDL), 26 hypercholesterolemia/dyslipidemia, 19, 24, 27 increases in various lipid fractions such as lipoprotein(a) (Lpa), 19 hyperhomocysteinemia (HHcy), 20,22,23,26.32 hyperuricemia, 22 hyperinsulinemia and insulin resistance, 27, 28 hyperleptinemia and leptin resistance, 27, 28 weight gain and metabolic syndrome. 21, 25, 26, 31 Chronic epilepsy has also been found to be associated with significantly increased carotid artery intima-media thickness (CA-IMT), 23, 26, 30 higher rates of early death from ischemic heart disease 18 and cerebrovascular stroke, 31 and (e) a combination of these etiologies.
In general, a normal full erection is defined as an erection to more than 908 that is firm to palpation. It is achieved within 15 min and lasts longer than 15 min. Normal erection involves relaxation of the smooth musculature of the cavernous tissue and penile arteriolar and arterial walls resulting in: (a) an increase in the blood flow in both diastolic and systolic phases due to arteriolar and arterial wall dilatation, and (b) venous compression due to trapping of the incoming blood by the expanding sinusoids and compression of the subtunical venular plexuses between the tunica albuginea and the peripheral sinusoids. These reduce the venous outflow and stretch the tunica to its capacity which encloses the emissary veins between the inner circular and the outer longitudinal layers with further decrease in the venous outflow to a minimum. These changes increase the intracavernous pressure (maintained at around 100 mm Hg) and raise the penis from the dependent position to the erect state (the full-erection phase). A further increase in pressure to several hundred millimeters of mercury results in contraction of the ischiocavernosus muscles and this produces the rigid-erection phase. 5 The hemodynamic of erection in normal and disease states can be determined using Penile Duplex Ultrasonography (PDU). PDU has been widely used to determine and document the presence of penile arterial insufficiency, inflow or outflow types of ED, venous leak, signs of atherosclerosis and scarring or calcification of erectile tissue, in order to predict the response of ED to medications. Various parameters, such as the diameter of the cavernosal artery, peak systolic flow velocity (PSV) and the degree of arterial dilatation and acceleration time, have been suggested for the diagnosis of arteriogenic ED, while end-diastolic flow velocity (EDV) and resistance index (RI) have been suggested for the diagnosis of venous leak. RI is estimated by subtracting PSV from EDV and divided by PSV. 5, 33 PDU can be used to assess penile blood flow in men with epilepsy. PDU spectral wave analysis during full erection obtained after intracavernous injection of vasoactive substance (e.g. prostaglandin E1, or PGE1) has been considered to be the more accurate, most reliable and least invasive evidence-based diagnostic test for the evaluation of penile arterial insufficiency. 33 Previous studies have confirmed the sensitivity of PDU in the detection of arterial insufficiency in patients with various medical vascular diseases and those with risk factors for vascular diseases. [33] [34] [35] In the Mayo Clinic series, PDU examination with PSV less than 25 cm/s was found to have a sensitivity of 100% and a specificity of 95% for the diagnosis of severe systemic arterial disease in the same patients implicating the potentially important role of atherosclerosis. 35 In this investigation we hypothesized that ED in men with epilepsy may have a vascular etiology. To our knowledge, no previous studies have directly investigated the presence of vasculogenic ED in men with epilepsy. PDU was used to assess the status of penile blood flow. We also measured the intimamedia thickness of the carotid (CA-IMT) arteries using Duplex Ultrasonography, a sensitive method for detection of early cerebral and systemic atherosclerosis. 36 Patients with normal and abnormal penile arterial blood flow findings were compared in relation to scores of erectile function; demographic-, clinical-, hormonaland vascular-related risk variables including CA-IMT. The relationship between CA-IMT values and PDU variables was also determined.
Materials and methods
We approached 100 adult men with epilepsy to participate in this study and 47 ultimately agreed to undergo PDU examination. Participating subjects ranged in age between 20 and 48 years and duration of illness ranged from 3 to 35 years. Seizure types were diagnosed according to the International League Against Epilepsy (ILAE) criteria. 37 Patients were recruited from the out-patient epilepsy clinic of the Department of Neurology and Psychiatry of Assiut University Hospital, Assiut, Egypt (over a period of one year). All patients were compliant with treatment with conventional AEDs [CBZ or VPA monotherapies or polytherapy (CBZ + VPA)] for at least 6 months before participation in the study. Twenty-five healthy men matched for age-(range: 20-48 years; mean: 30.36 AE 7.59), educational level and socioeconomic status were also included for comparisons. Control subjects were chosen from the patients' healthy relatives who agreed to undergo PDU exam. Excluded were subjects (patients and controls) with any of the following: (1) history of neurological disorder other than epilepsy likely to affect erectile function, (2) concomitantly known vascular risk or manifest atherosclerotic vascular disease [e.g. heavy smoking, diabetes mellitus (DM), hypertension (HTN), hypercholesterolemia/dyslipidemia, hyperuricemia, coronary artery disease (CHD) such as angina pectoris or myocardial infarction (MI)], heart failure, cerebrovascular stroke or transient ischemic attacks (TIAs), (3) history of systemic illness unrelated to vascular disease likely to affect erectile function (e.g. renal failure, serum creatinine concentration >150 mmol/l, chronic hepatic illness), (4) history of clinically significant genitourinary disease, pelvic trauma, pelvic surgery, or radiation therapy, (5) alcoholism or diagnosed substance abuse and/or previous hospitalization for substance abuse, (6) use of any regular medication(s) in addition to AEDs (e.g. antihypertensive drugs, heart medications, antidepressants, tranquilizers, and sedatives), and (7) current or recent treatment of ED with intracorporeal injection or application of vasoactive drugs.
The study protocol was approved by the Ethical Committee of the Faculty of Medicine of Assiut University, Assiut, Egypt and all patients and control subjects gave their informed consents to participate in this study.
All patients and healthy subjects underwent the same research protocol, which included the procedures described below. 
Psychiatric evaluation
Clinical psychiatric interview and evaluation of patients was done by a psychiatrist using the diagnostic criteria of Diagnostic and Statistical Manual of Mental Health Disorders (4th edition) or DSM-IV. 40 Differentiation between psychiatric symptoms and disorders was made by clinical judgment. In patients with coexisting symptoms, a trained psychologist (under supervision of the psychiatrist) administered Arabic translated questionnaires including the Beck Depression Inventory (2nd edition) (BDI-II) 41 ,42 and
Hamilton Anxiety Rating Scale (HAM-A) 43, 44 to screen and assess the severity of psychiatric symptoms. The BDI-II consists of 21 items, each item corresponding to a symptom of depression, and one sums across items to yield a single overall score. Accordingly, subjects were divided into: (a) no or minimal symptoms (score ranging from 0 to13), (b) mild depressive symptoms (score ranging from 14 to 19), (c) moderate depressive symptoms (score ranging from 20 to 28), and (d) severe depressive symptoms (score ranging from 29 to 63). The HAM-A consists of 14 items, each scored on a 5-point scale, ranging from 0 (not present) to 4 (severe). Accordingly, subjects were divided into: (a) no symptoms (score ranging from 0 to 13), (b) mild anxiety symptoms (score ranging from 14 to 17), (c) moderate anxiety symptoms (score ranging from 18 to 24), and (d) severe anxiety symptoms (score ranging from 25 to 30).
Laboratory investigations
Study procedures included control for timing of blood sampling which were withdrawn at 8.00-10.00 am after an overnight fast and being seizure free for at least 72 h (as any postictal central neurochemical dysfunction, is recognized to reverse within hours). The following laboratory tests were completed: (a) standard tests which included complete blood count (CBC) and serum concentrations of creatinine, liver enzymes and fasting blood glucose, and (b) specific tests which included measurements of serum concentrations of free testosterone, prolactin, free thyroxin (FT4), thyroid stimulating hormone (TSH) and sex hormone binding globulin (SHBG). Assessment protocols were performed according to the recommendations of the manufacturers. The concentrations of serum prolactin, FT4 and TSH were measured by IMMULITE reproductive hormone assays from Diagnostic Product Cooperation (Los Angeles, USA). The concentrations of free testosterone were measured by enzyme immunoassay method (ELISA) (BioSource Europe S.A. Rue de I'Industrie, 8-B-1400 Nivelles, Belgium) and SHBG concentrations were measured by ELISA kits (IBL International GMBH, Hamburg, Germany). Concentrations were assessed in close temporal proximity to the clinical evaluation and interview of patients. Serum levels of AEDs were measured as part of the investigation in batched assays through Therapeutic Drug Monitoring (TDM) Laboratory of Assiut University Hospital, Assiut, Egypt, using Fluorescence Polarization Immunoassay System of Abbott, TDxFLX apparatus (Abbott Lab, Wiesbaden, Germany). The approximated reference therapeutic serum levels of CBZ are 4-10 mg/ml and 50-100 mg/ml for VPA. 24 
Assessment of penile blood flow status
PDU with intracavernous injection (ICI) of prostaglandin E1 (PGE1) was performed (by the specialized radiologist) in a private room that was partially lighted and slightly warmed. A short history was taken from the patient and the entire procedure was explained in clear words by the experienced radiologist. The equipment used was the GE Logic Three Color Doppler Machine (GE L3-India). This equipment has a short foot print linear transducer (5-10 MHz). The procedure was done while the patient was in supine position. Sterilization of the shaft of the penis and a light tronique was applied to the root of the penis with light tightness before the injection. The corpus spongiosus was clinched before the injection to protect the urethra. Prostaglandin E1 (PGE1) (alprostadil) in a dose of 5-15 mg was carefully given while the needle (28 gauge short needle or insulin injection needle) was in a perpendicular direction at the lateral aspect of the mid shaft of the penis and away from the site of the urethra and dorsal nerve of the penis. The tourniquet was then removed. Alprostadil was formed of PGE1 precipitate added to 60 mg papaverine and 24 ml Ringer's solution and used as 0.5-1 ml dose. The initially used dose was adapted to the history of the patient and reduced in the presence of suspected psychogenic ED for fear of occurrence of prolonged erection or priapism. The patient was then allowed to perform tactile self-genital stimulation in privacy (to prevent the inhibitory effect of sympathetic activity and optimize penile vascular and corporeal smooth muscle relaxation) for about 5-10 min to attain full and best quality erection and obtain the most reliable dynamic vascular response by PDU. The erectile response was periodically evaluated for both rigidity and duration. All patients were questioned regarding the erectile response to vasoactive agents during PDU compared to erections achieved at home in private to assess levels of test-associated anxiety. If there was no significant difference in the quality of erection, we did not re-dose to achieve maximal cavernosal arterial and smooth muscle relaxation. If there was difference in the degree of erectile quality, we performed second intracavernous injection and sexual stimulation.
PDU Doppler spectral wave form traces were obtained at 20 min intervals after full erection and not obtained in the flaccid state as the latter has been proven to be inaccurate in the functional evaluation of the penile vascular system. In the flaccid state, the cavernous smooth musculature and the smooth muscles of the arteriolar and arterial walls of the penile tissue are tonically contracted, allowing only a small amount of arterial flow for nutritional purposes. Therefore, PDU examination was conducted only in the full erection state. The examination began by gray scale assessment for calcifications, fibrosis, cavernosal arterial atheromas or tunical fibrosis. Color flow mapping was performed to assess the anatomy of the cavernosal arteries, location and variations.
The penile peak systolic blood flow velocity (PSV), end-diastolic blood flow velocity (EDV) and the resistance index (RI) of cavernosal arteries from each side (right and left) were recorded. Measurements from both sides were summated and the mean of the two sides was recorded and used for final statistical analysis if asymmetrical cavernous arterial flows greater than 10 cm/s were not identified between both sides. 34 Accordingly, if the person achieved an erection as good or better than his erectile capacity at home, a PSV > 35 cm/s was considered indicative of normal penile arterial system, borderline if PSV was 25-35 cm/s and with arterial insufficiency if PSV was <25 cm/s. In general, during normal erections when inflow is increased, there should be no significant outflow of blood from the penis. If this portion of the test was normal and the end-diastolic flow was zero or less, the patient was considered not to have an outflow problem. If there was an outflow leak, the EDV was greater than zero. An EDV > 5 cm/s and RI < 0.95 were considered diagnostic for venous leak. It was possible for patients to have a combination of arterial insufficiency and venous leak. 5 Observation of each patient, particularly those with good erection was done for 0.5-3 h, to exclude the possibility of priapism.
Evaluation of the CA-IMT
CA-IMT was undertaken using high resolution Echo Color Doppler. Examination was performed manually with measurements taken twice by the same radiologist using a 5 MHZ linear transducer of a Color Duplex Flow Imaging System (Acuson 128 XP, Acuson Corporation, Mountain View, CA, USA) which operates in several modes: real time B, color Doppler and spectral Doppler modes. CA-IMT was measured in a 1 cm segment proximal to the dilatation of the carotid bulb, the area of bifurcation, and the proximal part of the internal carotid artery. 36 Measurements from both sides were summated and the means were recorded.
Statistical analysis
Calculations were performed using SPSS, version 12.0. Data were examined for normality using the Kolmogorov-Simirnov test. The Student's t test was used for comparison of means of normally distributed parameters while Mann-Whitney U test was used for comparison of non-normally distributed parameters (e.g. scores of BDI-II and HAM-A and concentrations of free testosterone and SHBG). To determine the relationship between PSV, EDV and RI and CA-IMT, a multivariate analysis was undertaken using PSV, EDV and RI values as the dependent variables. Bivariate correlations were examined between dependent variables and the independent variables or confounders (e.g. age, duration of illness, systolic blood pressure, diastolic blood pressure, scores of IIEF-5, BDI-II, HAM-A and CA-IMT) (r and p values). Independent variables which had no significant correlation with PSV, EDV and RI values were then excluded. The model was adjusted for other confounders. For all tests, values of P < 0.05 were considered statistically significant.
Results
This epilepsy cohort consisted of 47 adult males with primary epilepsy (mean age = 30.98 AE 6.82 years, duration of illness = 13.98 AE 7.06 years). Patients were treated with one or more conventional AED(s) for a mean period of 9.65 AE 3.05 years (range: 3-16 years). All patients had normal CT or MRI of the brain and all were without focal or pelvic abnormalities on urologic examination. Table 2 shows erectile function scores and depression and anxiety scores in relation to the type of epilepsy and AEDs and the degree of seizure control. Compared to controls, lower scores of IIEF-5 and higher scores of BDI-II were reported in patients with complex partial epilepsy/ partial epilepsy with secondary generalization with poor seizure control on AEDs. Lower levels of free testosterone were reported with CBZ (monotherapy or polytherapy). Higher levels of SHBG were associated with polytherapy (CBZ + VPA). No significant differences were reported in the concentrations of prolactin (8.7 AE 3.4 ng/ml versus 9.2 AE 3.6; P = 0.118), FT4 (0.39 AE 0.10 ng/dl versus 0.46 AE 0.29; P = 0.651) and TSH (2.23 AE 1.77 mIU/ml versus 2.55 AE 0.96; P = 0.463).
Poor seizure control on AEDs was associated with higher scores of IIEF-5, higher BDI-II, and lower levels of free testosterone and higher levels of SHBG. Table 3 shows the results of PDU and CA-IMT in relationship to epilepsy-and treatment-related variables. Compared to controls, lower values of PSV were reported in patients with temporal lobe epilepsy, left sided epileptic activity, and poorer seizure control on AEDs. Patients had higher values of CA-IMT, particularly those taking CBZ and those with poor seizure control. Eleven patients out of 13 with ED (84.62%, 11/ 13) had abnormal PDU parameters suggesting vasculogic ED (PSV: 28.23 AE 6.1 cm/s versus 52.29 AE 14.55 for control subjects; P = 0.0001 and 56.32 AE 16.45 cm/s for patients with high PSV; P = 0.0001). PDU results showed evidence of arterial insufficiency in 5 patients (45.45%) (Fig. 1B) while the remaining 6 (54.55%) had mixed arterial insufficiency and venous leak as evidenced by low values of PSV and RI and high values of EDV (Fig. 1C) . One patient had atheroma in one carotid artery but did not have abnormalities in PDU (Fig. 1D) . Table 4 shows the differences between patients with high PSV (52.29 AE 14.55 cm/s, n = 36, 76.60%) and low PSV (28.23 AE 6.10 cm/s, n = 11, 23.40%) in relationship to demographic-, clinical-, psychosocialand vascular-risk factors. Patients with low PSV had lower IIED-5 scores, higher EDV, lower RI, higher diastolic blood pressure and higher CA-IMT values. No significant differences were identified between patients with high and low PSV on the BDI-II or HAM-A. Correlations between PDU values and demographic-, clinical-, psychosocial-and imaging-confounders were shown in Table 5 which demonstrates significant correlations between PDU variables and the duration of illness, BDI-II and HAM-A scores, and values of CA-IMT. In multivariate analysis, the association between PDU parameters and values of CA-IMT remained significant even after adjustment of other confounding variables as shown in Table 6 .
Discussion
Men with epilepsy frequently experience poor sexual performance or potency which is reflected in their reduced rates of fertility and marital status. This is confirmed in the present investigation as we found a higher frequency of ED (27.66%) and lower scores of erectile function testing. 4, [6] [7] [8] [9] [10] [11] [12] 17 Previously, psychogenic impotence was believed as the most common type of ED with up to 70% of impotent men with epilepsy thought to suffer from this condition. 6, 8, [10] [11] [12] [13] [14] [15] [16] [17] This belief has given way to the realization that most men with epilepsy and ED have mixed functional (psychogenic) and metabolic (endocrinal) ED due to disturbances in sex hormones caused by epilepsy itself and adverse effects of antiseizure medications. 4, 6, [10] [11] [12] [13] [14] [15] [16] [17] However, given the growing evidence of increased atherosclerotic risk in people with chronic epilepsy, [18] [19] [20] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] this work was designed to investigate the possibility that abnormalities in penile blood flow and evidence for vasculogenic ED in patients with epilepsy. The approach here was novel as it directly investigated the status of penile blood flow using the high-resolution PDU after induction of erection by intracavernous injection of vasoactive substance (e.g. alprostadil or PGE1). PDU is a sensitive, reliable, relatively non-invasive and non-expensive method to assess penile blood flow state. 33 Two major outcomes were derived from this study: (1) penile arterial insufficiency is not infrequent in men with epilepsy with ED, and (2) men with chronic epilepsy presented with objective evidence of atherosclerotic risk demonstrated by increased values of CA-IMT which was significantly correlated with the abnormalities of penile blood flow suggesting that a vasculogenic element of ED may be related to systemic atherosclerotic risk. Details of these findings follow below. First, our findings indicate that penile arterial insufficiency is common in men with epilepsy with ED suggesting that the problem may be of vasculogenic origin. Nearly 23.40% (n = 11) of the sample of men with epilepsy had either penile arterial insufficiency alone (10.63%, n = 5) as evidenced by low PSV or a Table 2 Significance between different studied groups in scores of erectile function, psychosocial-and hormonal-related variables in relationship to epilepsy-and treatment-related variables. mixed penile arterial insufficiency and venous leak (12.77%, n = 6) as evidenced by high EDV. All patients with low PSV had ED and lower scores of IIEF-5 while those with high PSV had neither PDU abnormalities nor ED. The superior sensitivity and specificity of PDU over penile angiography has been reported by several investigators, 45, 46 and even PSV has been considered by some as the most accurate indicator of arterial disease. 47 We suggest that venous leak is secondary to penile arterial insufficiency, a suggestion supported by the significant correlations between PSV and EDV and RI and between EDV and RI. This is further supported by the finding that veno-occlusive dysfunction could be induced by cavernosal ischemia in animal models. 48 Second, our findings indicate that men with chronic epilepsy exhibited objective increase in atherosclerotic risks as evidenced by high values of CA-IMT. 26 We previously reported that high values of CA-IMT were associated with CBZ, a commonly used AED worldwide. CBZ is an EI-AED that is principally metabolized in the hepatic P450 system (CYP450). The P450 system has a multitude of functions which include the synthesis and breakdown of endogenous substances resulting in metabolic side effects. 49 Several cross-sectional and prospective studies in patients with epilepsy have demonstrated that long-term use of CBZ may result in an adverse vascular risk profile. [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] We also reported that patients who were lacking control on AEDs had higher values of CA-IMT (which reflect the longer duration of illness, longer-term treatment with AEDs and use of combination therapy). 26 Furthermore, the finding that patients with lower PSV had higher values of diastolic blood pressure compared to control subjects, the higher CA-IMT compared to patients with high PSV values and the significant correlation between CA-IMT and PSV, EDV and RI in multivariate analysis, all suggesting that a vasculogenic element of ED may be related to systemic atherosclerotic risk in the same group of patients independent of other potential confounders.
The hypothesis that ED in men with epilepsy may be caused by penile vascular abnormalities is not surprising due to the following Table 4 Difference between patients with high and low peak systolic velocity (PSV) in relation to demographic-, clinical-, laboratory-, psychosocial-and vascular-risk factors. facts: (1) the corpus cavernosum is a modified vascular tissue which is closely related to systemic vasculature, affected by various vascular risk factors and atherosclerosis and its diseases. For example, hypertension is a well-recognized risk factor for arteriosclerosis with a prevalence of about 45% in one series of impotent men. In patients with hypertension, an increase in peripheral vascular resistance and alteration in the vessel architecture may result in an increase in wall-to-lumen ratio and reduction in dilatory capacity which may contribute to impotence with hypertension. 45 In diabetes mellitus, ED has been reported in 35-75% of men. In diabetic men with ED, a PDU study after intracavernous injection of PGE1 revealed a high prevalence (>75%) of penile arterial insufficiency and pathologic change in the cavernous arteries. 35 Hyperlipidemia, a well-known risk factor for atherosclerosis, enhances the deposition of lipid in the vascular lesions and causes atherosclerosis and eventual occlusion. The atherosclerotic lesions can extend to the internal pudendal or cavernous arteries to reduce inflow. Ultrastructural studies of cholesterol-fed rabbits have also revealed early atherosclerotic changes in the corpus cavernosum, 50 (2) recent studies indicated that the IMT of the cavernous intima-media thickness has a strong direct correlation with the IMT of the carotid and femoral arteries. 51 Although not our aim, but as hypothesized and in accord with previous studies, we found that patients with epilepsy had a higher frequency of depression (59.57%), mostly of a severe degree (53.57%). Scores of IIEF-5 were found to be significantly correlated with BDI-II and HAM-A. [12] [13] [14] [15] [16] [17] The financial stress, poor cultural approach to epilepsy, unemployment and inability to drive, all result in low self-esteem, lessened well-being, social isolation, stigmatization, psychiatric abnormalities, hyposexuality and poor quality of life. We also reported lower levels of free testosterone with CBZ (monotherapy or polytherapy) and higher levels of SHBG with polytherapy (CBZ + VPA). 4, 6 It is well known that testosterone enhances sexual interest, increases frequency of sexual acts, and increases the frequency of nocturnal erections. Higher levels of SHBG would be expected to produce sexual dysfunction by decreasing the serum levels of free testosterone and/or albumin bound testosterone. SHBG is the most important regulator for the biologic effect of the testosterone on the target tissue (i.e. it decreases the activity of the testosterone on the target cells 52 ). The main strength of this study is that it is the first to directly investigate patients with epilepsy for the presence of a vascular element for ED. However, this study also has limitations: (1) the number of patients is relatively small. Nevertheless, the limited sample size is not likely to detract from the validity of our main findings. The present investigation may be considered a preliminary hypothesis for further examination in larger population-based samples, (2) ED in men is a disorder of high prevalence ranging from 2 to 18.9% in younger men (25-40 years in age) according to different population studies, and up to 50-80% of men over age of 40, even reaching as high as 86% in men 80 years and older. 53 Hence, the frequency of ED might be increased among patients with epilepsy compared to the general population, (3) repeated measurements were not made to account for within-individual variability in the PDU measurements, single measurements may be defensible given the relatively invasive nature of the method. This is exemplified by the fact that 53% of our original sample of patients refused to do PDU exam with intracavernous injection of PGE1, (4) given the cross-sectional design of this study, the temporal relationship between the increase in changes in vascular risk factors and changes in the penile arterial blood flow and vascular wall changes of the carotid arteries and the onset of epilepsy remain unknown. (5) Some authors suggested that although cavernous PSV is generally considered a major parameter in evaluation of penile arterial blood flow, it can be associated with false positives and negatives because of anatomic variations of the cavernous artery, the insufficient characterization of an early phase of vascular disease and the influence of adrenergic tone. 54 
Conclusions
Vasculogenic ED appears to be frequent in men with epilepsy and its relationship to systemic atherosclerosis cannot be excluded. The results of this study may have implications for early prevention and direct interventions including medical treatments. Medical treatment such as antidepressants, vasodilators and folate and vitamin supplements may be needed for severe conditions to improve the overall quality of life of patients with epilepsy. EDV, end-diastolic velocity; RI, resistance index; BDI-II, Beck Depression Inventory2nd edition; HAM-A, Hamilton Anxiety Rating Scale. * P < 0.05. ** P < 0.01.
